Clinical evaluation of an Ayurvedic formulation in the management of Allergic Rhinitis-A pilot study

CCRAS0 个研究点目标入组 107 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Patients either sex aged between 18 to 65 years.
•2. Clinical diagnosis persisting symptoms of Allergic rhinitis, X-ray (PNS), Nasal endoscopy and laboratory investigations etc.
•3. Able and willing to participate and provide signed informed consent.

•1.History of chronic nasal or upper respiratory tract symptoms or disorders other than allergic rhinitis.
•2.History of non allergic rhinitis, chronic sinusitis or serve asthma.
•3.Patients with nasal anatomical defects (deviated nasal septum).
•4.Patients with acute episodes i.e. fever/earache/headache.
•5.Patients with associated tonsillitis or airway obstructions (adenoids).
•6.Has a nasal condition likely to affect the outcome of the study.
•7.Any treatment of H1 antihistamine medication, Non-steroidal analgesies. Corticosteroids Nasal drops, Leukotriene antagonists, Nasal vasoconstrictors.
•8.Pregnant ladies and Lactating mothers.
•9.Patients suffering from any debilitating chronic disease like tuberculosis, Uncontrolled Diabetes mellitus
•10.Any unstable cardio-vascular diseases
•11.Patients with evidence of malignancy.
•12.Patients with concurrent hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT) > 2 times upper normal limit or Renal Disorders (defined as S. creatinine > upper limit of Lab. value), Pulmonary Dysfunction (Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD])
•13.Patient has an acute mental disorder
•14.Patients who are currently participating in any other clinical trial.

发起方

CCRAS